Radioactive iodine (RAI) therapy for metastatic differentiated thyroid cancer
- 1 June 2017
- journal article
- Published by Elsevier in Best Practice & Research Clinical Endocrinology & Metabolism
- Vol. 31 (3) , 279-290
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Differentiated Thyroid Cancer Patients More Than 60 Years Old Paradoxically Show an Increased Life ExpectancyJournal of Nuclear Medicine, 2015
- Relationship between positive thyroglobulin doubling time and 18F-FDG PET/CT-positive, 131I-negative lesionsNuclear Medicine Communications, 2014
- Twenty-Five Years After Chernobyl: Outcome of Radioiodine Treatment in Children and Adolescents With Very High-Risk Radiation-Induced Differentiated Thyroid CarcinomaThe Journal of Clinical Endocrinology & Metabolism, 2013
- Life Expectancy Is Reduced in Differentiated Thyroid Cancer Patients ≥ 45 Years Old with Extensive Local Tumor Invasion, Lateral Lymph Node, or Distant Metastases at Diagnosis and Normal in All Other DTC PatientsThe Journal of Clinical Endocrinology & Metabolism, 2013
- Peace of mind for patients with differentiated thyroid cancer?Nuklearmedizin-Nuclear Medicine, 2013
- Total Thyroidectomy and Adjuvant Radioiodine Treatment Independently Decrease Locoregional Recurrence Risk in Childhood and Adolescent Differentiated Thyroid CancerJournal of Nuclear Medicine, 2007
- Real-Time Prognosis for Metastatic Thyroid Carcinoma Based on 2-[18F]Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography ScanningThe Journal of Clinical Endocrinology & Metabolism, 2006
- Papillary and Follicular Thyroid CarcinomaNew England Journal of Medicine, 1998
- Measurement of serum TSH and thyroid hormones in the management of treatment of thyroid carcinoma with radioiodineBritish Journal of Radiology, 1977
- RADIOACTIVE IODINE THERAPYJAMA, 1946